Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 59

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 59
---
 

38

Restructuring and other (income) charges, net

Three and Nine Months Ended September 30, 2025 vs. 2024 

Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Work force reductions and other $0.3 $— $8.0 $— Performance Chemicals repositioning0.7 2.0 2.1 3.4 Restructuring charges$1.0 $2.0 $10.1 $3.4 North Charleston plant transition— 1.3 — 4.9 Other (income) charges, net$— $1.3 $— $4.9 Restructuring and other (income) charges, net (1)$1.0 $3.3 $10.1 $8.3 _______________(1) See Note 11 for more information. 

Goodwill impairment charge

Three and Nine Months Ended September 30, 2025 vs. 2024 

Goodwill impairment charge of zero and $183.8 million for the three and nine months ended September 30, 2025, respectively, within our Advanced Polymer Technologies reportable segment. Goodwill impairment charge of zero and $306.6 million for the three and nine months ended September 30, 2024, respectively, within our Performance Chemicals reportable segment. See Note 7 for more information.

Acquisition-related costs

Three and Nine Months Ended September 30, 2025 vs. 2024 

Acquisition-related (income) costs were zero for the three and nine months ended September 30, 2025, and $(0.1) million and zero for the three and nine months ended September 30, 2024, respectively. All charges relate to the integration of Ozark Materials into our Performance Chemicals reportable segment. 

Other (income) expense, net

Three and Nine Months Ended September 30, 2025 vs. 2024Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Foreign currency transaction (gain) loss $0.2 $1.0 $(1.3)$3.1 (Gain) loss on strategic investments (1)— 2.2 2.5 2.1 CEO severance charges— 4.